Literature DB >> 14762348

Propensity case-matched analysis of off-pump coronary artery bypass grafting in patients with atheromatous aortic disease.

Ram Sharony1, Eugene A Grossi, Paul C Saunders, Aubrey C Galloway, Robert Applebaum, Greg H Ribakove, Alfred T Culliford, Marc Kanchuger, Itzhak Kronzon, Stephen B Colvin.   

Abstract

OBJECTIVE: Atheromatous aortic disease is a risk factor for excessive mortality and stroke in patients undergoing coronary artery bypass grafting. Outcomes of off-pump coronary artery bypass grafting and coronary artery bypass grafting with cardiopulmonary bypass in patients with severe atheromatous aortic disease were compared by propensity case-match methods.
METHODS: Routine intraoperative transesophageal echocardiography identified 985 patients undergoing isolated coronary artery bypass grafting with severe atheromatous disease in the aortic arch or ascending aorta. Off-pump coronary artery bypass grafting was performed in 281 patients (28.5%). Propensity matched-pairs analysis was used to match patients undergoing off-pump coronary artery bypass grafting (n = 245) with patients undergoing coronary artery bypass grafting with cardiopulmonary bypass.
RESULTS: Univariate analysis revealed decreased hospital mortality (16/245, 6.5% vs 28/245, 11.4%; P =.058) and stroke prevalence (4/245, 1.6% vs 14/245, 5.7%; P =.03) in off-pump coronary artery bypass grafting compared with coronary artery bypass grafting with cardiopulmonary bypass. Freedom from any postoperative complication was higher in off-pump coronary artery bypass grafting compared with coronary artery bypass grafting with cardiopulmonary bypass (226/245, 92.2% vs 196/245, 80.0%; P <.001). Multivariable analysis of preoperative risk factors showed that increased hospital mortality was associated with coronary artery bypass grafting with cardiopulmonary bypass (odds ratio = 2.7; P =.01), fewer grafts (P =.05), acute myocardial infarction (odds ratio = 11.5; P <.001), chronic obstructive pulmonary disease (odds ratio = 2.4; P =.03), previous cardiac surgery (odds ratio = 10.2, P =.05), and peripheral vascular disease (odds ratio = 2.1; P =.05). Cardiopulmonary bypass was the only independent risk factor for stroke (odds ratio = 3.6, P =.03). At 36 months' follow-up, comparable survival was observed in the off-pump coronary artery bypass grafting and coronary artery bypass grafting with cardiopulmonary bypass groups (74% vs 72%). Multivariable analysis revealed that renal disease (P <.001), advanced age (P <.001), previous myocardial infarction (P =.03), and lower number of grafts (P =.02) were independent risks for late mortality.
CONCLUSIONS: Patients with severe atherosclerotic aortic disease who undergo off-pump coronary artery bypass grafting have a significantly lower prevalence of hospital mortality, perioperative stroke, and overall complications than matched patients who underwent coronary artery bypass grafting with cardiopulmonary bypass. Routine intraoperative transesophageal echocardiography identifies severe atheromatous aortic disease and directs the choice of surgical technique.

Entities:  

Mesh:

Year:  2004        PMID: 14762348     DOI: 10.1016/j.jtcvs.2003.08.011

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  10 in total

1.  [Should we avoid cardiopulmonary bypass with diabetic patients?].

Authors:  A Albert; J Ennker; P Sergeant
Journal:  Clin Res Cardiol       Date:  2006-01       Impact factor: 5.460

Review 2.  The preoperative neurological evaluation.

Authors:  John Probasco; Bogachan Sahin; Tung Tran; Tae Hwan Chung; Liana Shapiro Rosenthal; Zoltan Mari; Michael Levy
Journal:  Neurohospitalist       Date:  2013-10

3.  Early neuropsychological dysfunction in elderly high-risk patients after on-pump and off-pump coronary bypass surgery.

Authors:  Tomoko Baba; Tomoko Goto; Kengo Maekawa; Asuka Ito; Atushi Yoshitake; Takaaki Koshiji
Journal:  J Anesth       Date:  2007-11-01       Impact factor: 2.078

4.  Predictors and outcome of gastrointestinal complications in patients undergoing cardiac surgery.

Authors:  Farzan Filsoufi; Parwis B Rahmanian; Javier G Castillo; Corey Scurlock; Peter E Legnani; David H Adams
Journal:  Ann Surg       Date:  2007-08       Impact factor: 12.969

5.  Improve morbidity and mortality in coronary artery bypass graft surgery for severe atherosclerosis.

Authors:  Shinji Kanemitsu; Sawaka Tanabe; Kensuke Ohue; Hiroyuki Miyagawa; Yoichiro Miyake; Manabu Okabe
Journal:  Ann Vasc Dis       Date:  2011-06-02

6.  Off-pump coronary artery bypass grafting.

Authors:  Jennifer S Lawton
Journal:  Mo Med       Date:  2012 Jul-Aug

Review 7.  On pump coronary artery bypass graft surgery versus off pump coronary artery bypass graft surgery: a review.

Authors:  Muhammad Shahzeb Khan; Mohammad Yousuf-Ul Islam; Muhammad Umer Ahmed; Faizan Imran Bawany; Asadullah Khan; Mohammad Hussham Arshad
Journal:  Glob J Health Sci       Date:  2014-03-24

Review 8.  Factors affecting mortality after coronary bypass surgery: a scoping review.

Authors:  Sean Christopher Hardiman; Yuri Fabiola Villan Villan; Jillian Michelle Conway; Katie Jane Sheehan; Boris Sobolev
Journal:  J Cardiothorac Surg       Date:  2022-03-21       Impact factor: 1.637

Review 9.  Off-Pump Coronary Artery Bypass Grafting: 30 Years of Debate.

Authors:  Mario Gaudino; Gianni D Angelini; Charalambos Antoniades; Faisal Bakaeen; Umberto Benedetto; Antonio M Calafiore; Antonino Di Franco; Michele Di Mauro; Stephen E Fremes; Leonard N Girardi; David Glineur; Juan Grau; Guo-Wei He; Carlo Patrono; John D Puskas; Marc Ruel; Thomas A Schwann; Derrick Y Tam; James Tatoulis; Robert Tranbaugh; Michael Vallely; Marco A Zenati; Michael Mack; David P Taggart
Journal:  J Am Heart Assoc       Date:  2018-08-21       Impact factor: 5.501

Review 10.  Intimal aortic atherosclerosis in cardiac surgery: surgical strategies to prevent embolic stroke.

Authors:  Wiebe G Knol; Ricardo P J Budde; Edris A F Mahtab; Jos A Bekkers; Ad J J C Bogers
Journal:  Eur J Cardiothorac Surg       Date:  2021-12-01       Impact factor: 4.191

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.